+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 75Years
All Genders
ID03998852

Brain Imaging Study of Cholinergic and Dopaminergic Systems in Post-Stroke Apathy Using PET and MRI

Led by University Hospital, Bordeaux · Updated on 2026-06-10

30

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Apathy is a neurocognitive syndrome marked by reduced goal-directed behaviors, which lowers quality of life for patients and caregivers. This study focuses on post-stroke apathy PSA to better understand the roles of the cholinergic and dopaminergic systems in this condition. Researchers aim to clarify how these two neurotransmitter systems contribute to apathy by using advanced brain imaging techniques. Participants will undergo positron emission tomography PET molecular imaging with two radiotracers 18F-FDOPA to study dopamine activity and 18F-FEOBV to study acetylcholine activity. For the first time in apathetic patients, cholinergic function will be assessed alongside dopaminergic function. Magnetic resonance imaging MRI will also be performed on the same day as the 18F-FEOBV PET scan to provide detailed images of brain circuits. Neuropsychological evaluations, including monitoring physical and social activity via actigraphy over seven days and apathy scoring with the Lille Apathy Rating Scale, will complement imaging. Participants will be assessed mainly at the first visit on Day 0, with brain imaging, blood flow mapping, and multiple scales for apathy, anxiety, fatigue, and depression. A follow-up PET scan with 18F-FDOPA will occur between 7 and 30 days after the first visit. The study measures brain tracer uptake as the primary outcome. Safety and ability to complete follow-up visits are monitored, and participation lasts around one month. This comprehensive approach aims to identify brain circuits disrupted in apathy after stroke and guide future treatments.

CONDITIONS

Brief Title

In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.

Research Team

N

Nicolas BALAMOUTOFF

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here